Boulos & Cooper Pharmaceuticals Press Releases

• Published on January 17, 2019 - 12:29 GMT

  

  First-in-class antibiotic is safe in rats

  PERTH, WESTERN AUSTRALIA, AUSTRALIA, January 17, 2019 /⁨EINPresswire.com⁩/ -- A scientific paper published in the journal, Scientific Reports, has shown Ramizol® a first-in-class stilbene-based investigational antibiotic for the treatment of CDI is safe in …

  Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
• Published on June 19, 2018 - 14:21 GMT

  

  First-in-class drug Ramizol® active against antibiotic resistant C. difficle

  Ramizol® active against fidaxomicin, metronidazole and vancomycin resistant C.difficile strains isolated from US clinics PERTH, WESTERN AUSTRALIA, AUSTRALIA, June 19, 2018 /⁨EINPresswire.com⁩/ -- A scientific paper published in the journal, Diagnostic …

  Distribution channels: Banking, Finance & Investment Industry, Companies ...
• Published on April 9, 2018 - 23:33 GMT

  Sustained drug release and improved bioavailability of Ramizol®

  PERTH, WESTERN AUSTRALIA, AUSTRALIA, April 9, 2018 /⁨EINPresswire.com⁩/ -- A scientific paper has been published in the journal Drug Development and Industrial Pharmacy that shows improved sustained drug release and improved bioavailability of the …

  Distribution channels: Banking, Finance & Investment Industry, Companies ...